Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 25.2
(-1.18%)
SAR 25.2
(-1.18%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.1 Billion SAR | 1.69% |
| 2022 | 1.08 Billion SAR | -16.46% |
| 2021 | 1.29 Billion SAR | -4.2% |
| 2020 | 1.35 Billion SAR | 11.73% |
| 2019 | 1.2 Billion SAR | -69.19% |
| 2018 | 3.92 Billion SAR | 3104.44% |
| 2017 | 122.53 Million SAR | 7.61% |
| 2016 | 113.87 Million SAR | -62.23% |
| 2015 | 301.45 Million SAR | 1407.28% |
| 2014 | 20 Million SAR | 0.0% |
| 2013 | 20 Million SAR | 0.0% |
| 2012 | - SAR | 0.0% |
| 2011 | - SAR | 0.0% |
| 2010 | - SAR | 0.0% |
| 2009 | - SAR | 0.0% |
| 2008 | - SAR | 0.0% |
| 2007 | - SAR | 0.0% |
| 2006 | - SAR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.25 Billion SAR | 13.82% |
| 2024 Q2 | 1.49 Billion SAR | 19.76% |
| 2023 Q3 | 1.1 Billion SAR | -9.94% |
| 2023 Q2 | 1.22 Billion SAR | -2.26% |
| 2023 Q1 | 1.25 Billion SAR | 16.01% |
| 2023 Q4 | 1.1 Billion SAR | -0.42% |
| 2023 FY | 1.1 Billion SAR | 1.69% |
| 2022 Q4 | 1.08 Billion SAR | -12.16% |
| 2022 FY | 1.08 Billion SAR | -16.46% |
| 2022 Q1 | 1.34 Billion SAR | 3.6% |
| 2022 Q2 | 1.52 Billion SAR | 13.97% |
| 2022 Q3 | 1.23 Billion SAR | -19.45% |
| 2021 Q1 | 1.33 Billion SAR | -0.9% |
| 2021 FY | 1.29 Billion SAR | -4.2% |
| 2021 Q3 | 1.32 Billion SAR | 0.26% |
| 2021 Q4 | 1.29 Billion SAR | -2.64% |
| 2021 Q2 | 1.32 Billion SAR | -0.97% |
| 2020 Q4 | 1.35 Billion SAR | 1.54% |
| 2020 FY | 1.35 Billion SAR | 11.73% |
| 2020 Q2 | 1.33 Billion SAR | 13.89% |
| 2020 Q3 | 1.33 Billion SAR | -0.05% |
| 2020 Q1 | 1.16 Billion SAR | -3.34% |
| 2019 Q1 | 1.02 Billion SAR | -74.02% |
| 2019 FY | 1.2 Billion SAR | -69.19% |
| 2019 Q4 | 1.2 Billion SAR | -10.66% |
| 2019 Q3 | 1.35 Billion SAR | 107.62% |
| 2019 Q2 | 652.22 Million SAR | -36.08% |
| 2018 Q1 | 273.83 Million SAR | 123.47% |
| 2018 FY | 3.92 Billion SAR | 3104.44% |
| 2018 Q2 | 269.76 Million SAR | -1.49% |
| 2018 Q3 | 362.28 Million SAR | 34.3% |
| 2018 Q4 | 3.92 Billion SAR | 983.88% |
| 2017 Q3 | 112.06 Million SAR | -56.87% |
| 2017 Q1 | 116.04 Million SAR | 1.91% |
| 2017 FY | 122.53 Million SAR | 7.61% |
| 2017 Q4 | 122.53 Million SAR | 9.34% |
| 2017 Q2 | 259.83 Million SAR | 123.9% |
| 2016 Q3 | 1.11 Billion SAR | 31.17% |
| 2016 Q2 | 848.58 Million SAR | 59.32% |
| 2016 Q1 | 532.61 Million SAR | 76.68% |
| 2016 FY | 113.87 Million SAR | -62.23% |
| 2016 Q4 | 113.87 Million SAR | -89.77% |
| 2015 Q3 | 175 Million SAR | 75.0% |
| 2015 FY | 301.45 Million SAR | 1407.28% |
| 2015 Q4 | 301.45 Million SAR | 72.26% |
| 2015 Q2 | 100 Million SAR | 0.0% |
| 2015 Q1 | 100 Million SAR | 400.0% |
| 2014 FY | 20 Million SAR | 0.0% |
| 2014 Q4 | 20 Million SAR | -86.67% |
| 2014 Q3 | 150 Million SAR | 50.0% |
| 2014 Q2 | 100 Million SAR | 0.0% |
| 2014 Q1 | 100 Million SAR | 400.0% |
| 2013 Q4 | 20 Million SAR | -80.0% |
| 2013 FY | 20 Million SAR | 0.0% |
| 2013 Q1 | - SAR | -100.0% |
| 2013 Q2 | 90 Million SAR | 0.0% |
| 2013 Q3 | 100 Million SAR | 11.11% |
| 2012 Q4 | 20 Million SAR | 0.0% |
| 2012 FY | - SAR | 0.0% |
| 2012 Q3 | - SAR | 0.0% |
| 2011 FY | - SAR | 0.0% |
| 2010 FY | - SAR | 0.0% |
| 2009 FY | - SAR | 0.0% |
| 2008 FY | - SAR | 0.0% |
| 2007 FY | - SAR | 0.0% |
| 2006 FY | - SAR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 2.4 Million SAR | -45710.562% |